Integra LifeSciences Holdings
Integra LifeSciences Holdings Corporation manufactures and sells surgical instrument, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural r… Read more
Integra LifeSciences Holdings (IART) - Total Liabilities
Latest total liabilities as of September 2025: $2.61 Billion USD
Based on the latest financial reports, Integra LifeSciences Holdings (IART) has total liabilities worth $2.61 Billion USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Integra LifeSciences Holdings - Total Liabilities Trend (1995–2024)
This chart illustrates how Integra LifeSciences Holdings's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Integra LifeSciences Holdings Competitors by Total Liabilities
The table below lists competitors of Integra LifeSciences Holdings ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hertz Global Holdings Inc
NASDAQ:HTZ
|
USA | $22.77 Billion |
|
Jindal Saw Limited
NSE:JINDALSAW
|
India | ₹93.77 Billion |
|
Mama's Creations Inc.
NASDAQ:MAMA
|
USA | $12.31 Million |
|
Beijing SL Pharmaceutical Co Ltd
SHE:002038
|
China | CN¥327.96 Million |
|
Nuvoton Technology Corp
TW:4919
|
Taiwan | NT$18.98 Billion |
|
Suzhou New District Hi Tech Industrial Co Ltd
SHG:600736
|
China | CN¥59.74 Billion |
|
Shandong Intco Recycling Resources Co Ltd
SHG:688087
|
China | CN¥4.30 Billion |
|
mBank S.A.
PINK:MBAKF
|
USA | $258.84 Billion |
Liability Composition Analysis (1995–2024)
This chart breaks down Integra LifeSciences Holdings's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.14 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.51 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.72 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Integra LifeSciences Holdings's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Integra LifeSciences Holdings (1995–2024)
The table below shows the annual total liabilities of Integra LifeSciences Holdings from 1995 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $2.49 Billion | +13.58% |
| 2023-12-31 | $2.19 Billion | +5.21% |
| 2022-12-31 | $2.09 Billion | -0.58% |
| 2021-12-31 | $2.10 Billion | -0.13% |
| 2020-12-31 | $2.10 Billion | +11.33% |
| 2019-12-31 | $1.89 Billion | +8.91% |
| 2018-12-31 | $1.73 Billion | -22.98% |
| 2017-12-31 | $2.25 Billion | +132.26% |
| 2016-12-31 | $968.29 Million | -5.37% |
| 2015-12-31 | $1.02 Billion | +17.04% |
| 2014-12-31 | $874.30 Million | +66.20% |
| 2013-12-31 | $526.05 Million | -18.55% |
| 2012-12-31 | $645.82 Million | -0.87% |
| 2011-12-31 | $651.47 Million | +25.93% |
| 2010-12-31 | $517.35 Million | +4.47% |
| 2009-12-31 | $495.22 Million | -27.62% |
| 2008-12-31 | $684.23 Million | +22.71% |
| 2007-12-31 | $557.58 Million | +75.64% |
| 2006-12-31 | $317.46 Million | +100.14% |
| 2005-12-31 | $158.61 Million | +6.53% |
| 2004-12-31 | $148.89 Million | +3.40% |
| 2003-12-31 | $144.00 Million | +431.92% |
| 2002-12-31 | $27.07 Million | +15.04% |
| 2001-12-31 | $23.53 Million | -28.11% |
| 2000-12-31 | $32.73 Million | +15.66% |
| 1999-12-31 | $28.30 Million | +757.58% |
| 1998-12-31 | $3.30 Million | +26.92% |
| 1997-12-31 | $2.60 Million | +13.04% |
| 1996-12-31 | $2.30 Million | +15.00% |
| 1995-12-31 | $2.00 Million | -- |